Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes

Citations Over TimeTop 10% of 2016 papers

Abstract

Chronic hepatitis B, C, and D virus (HBV, HCV, and HDV) infections are the leading causes of liver disease and cancer worldwide. Recently, the solute carrier and sodium taurocholate co-transporter NTCP has been identified as a receptor for HBV and HDV. Here, we uncover NTCP as a host factor regulating HCV infection. Using gain- and loss-of-function studies, we show that NTCP mediates HCV infection of hepatocytes and is relevant for cell-to-cell transmission. NTCP regulates HCV infection by augmenting the bile-acid-mediated repression of interferon-stimulated genes (ISGs), including IFITM3. In conclusion, our results uncover NTCP as a mediator of innate antiviral immune responses in the liver, and they establish a role for NTCP in the infection process of multiple viruses via distinct mechanisms. Collectively, our findings suggest a role for solute carriers in the regulation of innate antiviral responses, and they have potential implications for virus-host interactions and antiviral therapies.

Related Papers

• → Structures of the Dimeric and Monomeric Chromanones, Gonytolides A–C, Isolated from the Fungus Gonytrichum sp. and Their Promoting Activities of Innate Immune Responses(2011)66 cited
• → LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection(2001)73 cited
• → The fifth dimension of innate immunity(2014)14 cited
• → Innate Immunity in Allergic Disease(2008)1 cited
• → The Innate Immunity(2016)